FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review

References

• Loeffler JS, Patchell RA, Sawaya R. Treatment of metastatic cancer. In Cancer: Principles and Practice of Oncology (5th Edition). Devita VT, Hellman S, Rosenburg SA (Eds). Lippincott–Raven Publishers, PA, USA, 2523–2536 (1997).
   Google Scholar
• Mor V, Laliberte L, Morris JN et al. The Karnofsky performance status scale: an examination of its reliability and validity in a research setting. Cancer53(9), 2002–2007 (1984).
   PubMed Web of Science ®Google Scholar
• Cella DF, Tulsky DS, Gray G et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J. Clin. Oncol.11(3), 570–579 (1993).
   PubMed Web of Science ®Google Scholar
• Weitzner MA, Meyers CA, Gelke CK et al. The functional assessment of cancer therapy (FACT) scale: development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer75(5), 1151–1161 (1995).
   PubMed Web of Science ®Google Scholar
• Mehta MP, Rodrigus P, Terhaard CH et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J. Clin. Oncol.21(13), 2529–2536 (2003).
   PubMed Web of Science ®Google Scholar
• Rivera E, Meyers C, Groves M et al. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer107(6), 1348–1354 (2006).
   PubMed Web of Science ®Google Scholar
• Rogers LR, Rock JP, Sills AK et al. Results of a Phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. J. Neurosurg.105(3), 375–384 (2006).
   PubMed Web of Science ®Google Scholar
• Shaw EG, Rosdhal R, D’Agostino RB Jr et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J. Clin. Oncol.24(9), 1415–1420 (2006).
   PubMed Web of Science ®Google Scholar
• Addeo R, Caraglia M, Faiola V et al. Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life. BMC Cancer25, 18 (2007).
   Google Scholar
• Butler JM Jr, Case LD, Atkins J et al. A Phase III, double-blind, placebo-controlled prospective randomized clinical trial of D-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int. J. Radiat. Oncol. Biol. Phys.69(5), 1496–1501 (2007).
   PubMed Web of Science ®Google Scholar
• Chang EL, Wefel JS, Maor MH et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery60(2), 277–283 (2007).
   PubMed Web of Science ®Google Scholar
• Doyle M, Bradley NM, Li K et al. Quality of life in patients with brain metastases treated with a palliative course of whole-brain radiotherapy. J. Palliat. Med.10(2), 367–374 (2007).
   PubMed Web of Science ®Google Scholar
• Li J, Bentzen SM, Li J et al. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int. J. Radiat. Oncol. Biol. Phys.71(1), 64–70 (2008).
   PubMed Web of Science ®Google Scholar
• Chang EL, Wefel JS, Hess KR et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol.10(11), 1037–1044 (2009).
   PubMed Web of Science ®Google Scholar
• Ma S, Xu Y, Deng Q et al. Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and gefitinib in a Chinese population. Lung Cancer65(2), 198–203 (2009).
   PubMed Web of Science ®Google Scholar
• Kelsey CR, Mukundan S Jr, Wang Z et al. Assessing neurotoxicity from the low-dose radiation component of radiosurgery using magnetic resonance spectroscopy. Neuro. Oncol.12(2), 145–152 (2010).
   PubMed Web of Science ®Google Scholar
• Walter J, Kuhn SA, Waschke A et al. Operative treatment of subcortical metastatic tumours in the central region. J. Neurooncol.103(3), 567–573 (2010).
   PubMedGoogle Scholar
• Hashem T, Kamal-Eldin K, Metwaly H et al. Prophylactic cranial irradiation (PCI) in high-risk breast cancer patients: preliminary data. J. Clin. Oncol.26, Abstract 11501 (2008).
   Google Scholar
• Bradley N, Davis L, Chow E. Symptom distress in patients attending an outpatient palliative radiotherapy clinic. J. Pain Symptom Manage.30(2), 123–131 (2005).
   PubMed Web of Science ®Google Scholar
• Bezjak A, Adam J, Barton R et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur. J. Cancer38(4), 487–496 (2002).
   PubMed Web of Science ®Google Scholar
• Zeng L, Sahgal A, Zhang L et al. Patterns of pain and functional improvement in patients with bone metastases after conventional external beam radiotherapy and a telephone validation study. Pain Res. Treat.1–9 (2011).
   Google Scholar
• Steinmann D, Schafer C, van Oorschot B et al. Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party. Strahlenther. Onkol.185(3), 190–197 (2009).
   PubMedGoogle Scholar
• Lee H, Friedman ME, Cukor P et al. Interactive voice response system (IVRS) in health care services. Nurs. Outlook51(6), 277–283 (2003).
   PubMed Web of Science ®Google Scholar
• Blondin JM, Abu-Hasaballah KS, Tennen H et al. Electronic versus paper diaries: a pilot study of concordance and adherence in head and neck cancer patients receiving radiation therapy. Head Neck Oncol.2, 29 (2010).
   PubMedGoogle Scholar
• Agel J, Rockwood T, Mundt JC et al. Comparison of interactive voice response and written self-administered patient surveys for clinical research. Orthopedics24(12), 1155–1157 (2001).
   PubMedGoogle Scholar
• Giesinger JM, Golser M, Erharter A et al. Do neurooncological patients and their significant others agree on quality of life ratings? Health Qual. Life Outcomes9(7), 87 (2009).
   Google Scholar
• Brown PD, Decker PA, Rummans TA et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life. Am. J. Clin. Oncol.31(2), 163–168 (2008).
   PubMed Web of Science ®Google Scholar
• Moinpour CM, Lyons B, Schmidt SP et al. Substituting proxy ratings for patient ratings in cancer clinical trials: an analysis based on a Southwest Oncology Group trial in patients with brain metastases. Qual. Life Res.9(2), 219–231 (2000).
   PubMed Web of Science ®Google Scholar
• Meyers CA, Smith JA, Bezjak A et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized Phase III trial. J. Clin. Oncol.22(1), 157–165 (2004).
   PubMed Web of Science ®Google Scholar
• Giovagnoli AR, Boiardi A. Cognitive impairment and quality of life in long-term survivors of malignant brain tumors. Ital. J. Neurol. Sci.15(9), 481–488 (1994).
   PubMedGoogle Scholar